Edward Erickson

Background

About Edward Erickson

Edward L. Erickson has extensive executive and board level experience in diagnostics/medical devices, therapeutics, and life science research products having served as chairman, president, CEO or a director of over a dozen companies in these industries. Most recently, Mr. Erickson was non-executive chairman of MDxHealth, S.A, a molecular diagnostics company He is also an advisor to entrepreneurial organizations. Previously, he served in top leadership roles, including president, CEO and/or chairman, of a number of venture-capital backed medical products companies, including Cholestech (diagnostics), DepoTech (pharmaceuticals/drug delivery) and Immunicon (diagnostics), which successfully completed initial public offerings under his leadership. Earlier in his career, he held senior executive positions at The Ares-Serono Group (now a unit of Merck KGaA) and Amersham International (acquired by GE). Mr. Erickson holds an MBA with high distinction from the Harvard Graduate School of Business Administration, where he was elected a Baker Scholar and was awarded the Loeb Rhoades Fellowship in Finance, and has B.S. and M.S. degrees in Mathematics from the Illinois Institute of Technology. He did military service as an officer in the U.S. Navy’s nuclear submarine force, including duty aboard the USS Nautilus (SSN-571), the world’s first nuclear submarine.